Merck & Co., Inc. (NYSE: MRK) reported earnings and sales for the second quarter of 2021. Worldwide sales edged up 22% year-over-year to $11.4 billion but failed to match the expectations. Net profit for the quarter was $1.21 billion or $0.48 per share compared to a profit of $2.34 billion or $0.92 per share last […]
Merck & Co., Inc. (NYSE: MRK) reported earnings and sales for the second quarter of 2021. Worldwide sales edged up 22% year-over-year to $11.4 billion but failed to match the expectations. Net profit for the quarter was $1.21 billion or $0.48 per share compared to a profit of $2.34 billion or $0.92 per share last […]
Merck & Co., Inc. (NYSE: MRK) reported earnings and sales for the second quarter of 2021.
Worldwide sales edged up 22% year-over-year to $11.4 billion but failed to match the expectations.
Net profit for the quarter was $1.21 billion or $0.48 per share compared to a profit of $2.34 billion or $0.92 per share last year.
The adjusted EPS increased by 28% to $1.31 per share.
